These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 10470178)
21. K-ras, p53, and DPC4 (MAD4) alterations in fine-needle aspirates of the pancreas: a molecular panel correlates with and supplements cytologic diagnosis. van Heek T; Rader AE; Offerhaus GJ; McCarthy DM; Goggins M; Hruban RH; Wilentz RE Am J Clin Pathol; 2002 May; 117(5):755-65. PubMed ID: 12090425 [TBL] [Abstract][Full Text] [Related]
22. K-ras mutation in focal proliferative lesions of human pancreas. Terhune PG; Phifer DM; Tosteson TD; Longnecker DS Cancer Epidemiol Biomarkers Prev; 1998 Jun; 7(6):515-21. PubMed ID: 9641496 [TBL] [Abstract][Full Text] [Related]
23. Diagnosis of pancreatic cancer by detecting telomerase activity in pancreatic juice: comparison with K-ras mutations. Uehara H; Nakaizumi A; Tatsuta M; Baba M; Takenaka A; Uedo N; Sakai N; Yano H; Iishi H; Ohigashi H; Ishikawa O; Okada S; Kakizoe T Am J Gastroenterol; 1999 Sep; 94(9):2513-8. PubMed ID: 10484017 [TBL] [Abstract][Full Text] [Related]
24. Detection of K-ras gene mutation at codon 12 by pancreatic duct brushing for pancreatic cancer. Liu F; Li ZS; Xu GM; Sun ZX; Zhou GX; Ren XX; Tu ZX; Gong YF Hepatobiliary Pancreat Dis Int; 2003 May; 2(2):313-7. PubMed ID: 14599992 [TBL] [Abstract][Full Text] [Related]
25. Predictive factors for pancreatic cancer in patients with chronic pancreatitis in association with K-ras gene mutation. Arvanitakis M; Van Laethem JL; Parma J; De Maertelaer V; Delhaye M; Devière J Endoscopy; 2004 Jun; 36(6):535-42. PubMed ID: 15202051 [TBL] [Abstract][Full Text] [Related]
26. Frequency of K-ras mutations in pancreatic intraductal neoplasias associated with pancreatic ductal adenocarcinoma and chronic pancreatitis: a meta-analysis. Löhr M; Klöppel G; Maisonneuve P; Lowenfels AB; Lüttges J Neoplasia; 2005 Jan; 7(1):17-23. PubMed ID: 15720814 [TBL] [Abstract][Full Text] [Related]
27. [Detection of K-ras gene mutations in DNA extracted from the plasma of patients with pancreatic cancer]. Feng D; Han T; Jiang Y; Yuan Z; Wang X; Jiang Z; Zhang S Zhonghua Wai Ke Za Zhi; 2000 Oct; 38(10):767-70. PubMed ID: 11832160 [TBL] [Abstract][Full Text] [Related]
28. Adenocarcinoma of the pancreas: detection of occult metastases in regional lymph nodes by a polymerase chain reaction-based assay. Demeure MJ; Doffek KM; Komorowski RA; Wilson SD Cancer; 1998 Oct; 83(7):1328-34. PubMed ID: 9762933 [TBL] [Abstract][Full Text] [Related]
29. p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma. Moskaluk CA; Hruban RH; Kern SE Cancer Res; 1997 Jun; 57(11):2140-3. PubMed ID: 9187111 [TBL] [Abstract][Full Text] [Related]
30. [Detection of hepatic micrometastasis in ductal pancreatic carcinoma by K-ras mutation analysis and determination of clinical relevance]. Bastian D; Gerdes B; Ramaswamy A; Tschammer C; Bartsch D Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):45-7. PubMed ID: 14518210 [TBL] [Abstract][Full Text] [Related]
31. Comparative analysis of K-ras point mutation, telomerase activity, and p53 overexpression in pancreatic tumours. Uemura K; Hiyama E; Murakami Y; Kanehiro T; Ohge H; Sueda T; Yokoyama T Oncol Rep; 2003; 10(2):277-83. PubMed ID: 12579258 [TBL] [Abstract][Full Text] [Related]
32. The utility of Ki-ras mutation analysis in the cytologic diagnosis of pancreatobiliary neoplasma. Dillon DA; Johnson CC; Topazian MD; Tallini G; Rimm DL; Costa JC Cancer J; 2000; 6(5):294-301. PubMed ID: 11079168 [TBL] [Abstract][Full Text] [Related]
33. K-Ras and microsatellite marker analysis of fine-needle aspirates from intraductal papillary mucinous neoplasms of the pancreas. Schoedel KE; Finkelstein SD; Ohori NP Diagn Cytopathol; 2006 Sep; 34(9):605-8. PubMed ID: 16900481 [TBL] [Abstract][Full Text] [Related]
34. A comparative analysis of pancreas cyst fluid CEA and histology with DNA mutational analysis in the detection of mucin producing or malignant cysts. Sreenarasimhaiah J; Lara LF; Jazrawi SF; Barnett CC; Tang SJ JOP; 2009 Mar; 10(2):163-8. PubMed ID: 19287110 [TBL] [Abstract][Full Text] [Related]
35. Ki-ras codon 12 point mutation and p53 mutation in pancreatic diseases. Yamaguchi K; Chijiiwa K; Noshiro H; Torata N; Kinoshita M; Tanaka M Hepatogastroenterology; 1999; 46(28):2575-81. PubMed ID: 10522044 [TBL] [Abstract][Full Text] [Related]
36. K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma. Wilentz RE; Chung CH; Sturm PD; Musler A; Sohn TA; Offerhaus GJ; Yeo CJ; Hruban RH; Slebos RJ Cancer; 1998 Jan; 82(1):96-103. PubMed ID: 9428484 [TBL] [Abstract][Full Text] [Related]
37. A prospective study of K-ras mutations in the plasma of pancreatic cancer patients. Mulcahy HE; Lyautey J; Lederrey C; qi Chen X; Anker P; Alstead EM; Ballinger A; Farthing MJ; Stroun M Clin Cancer Res; 1998 Feb; 4(2):271-5. PubMed ID: 9516910 [TBL] [Abstract][Full Text] [Related]
39. Direct sequencing analysis of exon 1 of the c-K-ras gene shows a low frequency of mutations in human pancreatic adenocarcinomas. Gonzalez-Cadavid NF; Zhou D; Battifora H; Bar-Eli M; Cline MJ Oncogene; 1989 Sep; 4(9):1137-40. PubMed ID: 2674856 [TBL] [Abstract][Full Text] [Related]
40. [Significance of ras mutations in pancreatic diseases]. Löhr M; Liebe S; Lowenfels AB Z Gastroenterol; 1998 Oct; 36(10):929-32. PubMed ID: 9846373 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]